Nivolumab, a programmed cell death protein 1 (PD-1) blocking antibody, is administered intravenously. The usual dosage for cancer patients is 3 milligrams per kilogram of body weight, given every two weeks [1][2]. This dosage is generally administered as an infusion over 30 minutes [2].
How is Nivolumab Administered?
Nivolumab is given as an intravenous infusion. The infusion typically lasts for 30 minutes [2]. Healthcare providers administer the medication [1][2].
What is Nivolumab Used For?
Nivolumab is used to treat certain types of cancer. These include melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), classical Hodgkin lymphoma (cHL), and urothelial carcinoma [1]. It is also used for specific types of head and neck squamous cell carcinoma (HNSCC), and esophageal squamous cell carcinoma (ESCC) [1].
What Happens if a Nivolumab Dose is Missed?
If a dose of nivolumab is missed, patients should contact their healthcare provider. The provider will determine when to administer the next dose and how to adjust the dosing schedule [3].
How Does Nivolumab Work?
Nivolumab works by blocking the PD-1 pathway. PD-1 is a protein found on immune cells called T cells. By blocking PD-1, nivolumab helps the immune system recognize and attack cancer cells [1].
What are the Side Effects of Nivolumab?
Common side effects of nivolumab include fatigue, rash, itching, diarrhea, nausea, and muscle or joint pain [1]. More serious side effects can occur, such as inflammation of organs like the lungs, colon, liver, kidneys, and endocrine glands, which can be life-threatening [1][2]. Patients should report any new or worsening symptoms to their doctor immediately [2].
What are the Risks Associated with Nivolumab Treatment?
The risks associated with nivolumab treatment stem from its mechanism of action, which involves activating the immune system. This can lead to immune-mediated side effects where the immune system attacks healthy tissues [1][2]. These can affect various organs and require prompt medical attention [1].
Can Nivolumab Be Used in Combination Therapy?
Yes, nivolumab can be used in combination with other cancer treatments. For example, it may be used with ipilimumab for melanoma and unresectable or metastatic melanoma [1]. It can also be combined with chemotherapy for certain types of lung cancer [1].
Where Can I Find More Information on Nivolumab Dosing?
Detailed prescribing information and guidelines for nivolumab dosing are available from healthcare professionals and official drug information resources [1][2][3].
*
**Cited Sources
1. https://www.cancer.gov/drug-types/nivolumab
2. https://www.drugs.com/nivolumab.html
3. https://www.mayoclinic.org/drugs-supplements/nivolumab-intravenous-route/proper-use/drg-20068100